Correlation Between OWC Pharmaceutical and Creative Edge

Can any of the company-specific risk be diversified away by investing in both OWC Pharmaceutical and Creative Edge at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OWC Pharmaceutical and Creative Edge into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OWC Pharmaceutical Research and Creative Edge Nutrit, you can compare the effects of market volatilities on OWC Pharmaceutical and Creative Edge and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OWC Pharmaceutical with a short position of Creative Edge. Check out your portfolio center. Please also check ongoing floating volatility patterns of OWC Pharmaceutical and Creative Edge.

Diversification Opportunities for OWC Pharmaceutical and Creative Edge

0.0

Correlation Coefficient

OWC Pharmaceutical  Creative Edge

Pay attention - limited upside

The 3 months correlation between OWC and Creative is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OWC Pharmaceutical Research and Creative Edge Nutrit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Creative Edge Nutrit and OWC Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OWC Pharmaceutical Research are associated (or correlated) with Creative Edge. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Creative Edge Nutrit has no effect on the direction of OWC Pharmaceutical i.e., OWC Pharmaceutical and Creative Edge go up and down completely randomly.

Pair Corralation between OWC Pharmaceutical and Creative Edge

Given the investment horizon of 90 days OWC Pharmaceutical Research is expected to under-perform the Creative Edge. But the pink sheet apears to be less risky and, when comparing its historical volatility, OWC Pharmaceutical Research is 9.92 times less risky than Creative Edge. The pink sheet trades about -0.13 of its potential returns per unit of risk. The Creative Edge Nutrit is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Creative Edge Nutrit on May 13, 2025 and sell it today you would earn a total of  0.00  from holding Creative Edge Nutrit or generate 9.223372036854776E16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

OWC Pharmaceutical Research  vs.  Creative Edge Nutrit

OWC Pharmaceutical

Risk-Adjusted Performance

Weakest

Over the last 90 days OWC Pharmaceutical Research has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in September 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Creative Edge Nutrit

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Creative Edge Nutrit are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Creative Edge showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with OWC Pharmaceutical and Creative Edge

The main advantage of trading using opposite OWC Pharmaceutical and Creative Edge positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OWC Pharmaceutical position performs unexpectedly, Creative Edge can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Creative Edge will offset losses from the drop in Creative Edge's long position.

The idea behind OWC Pharmaceutical Research and Creative Edge Nutrit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.